ANTIBODY DRUG CONJUGATES AND METHODS FOR MAKING THEREOF

This application discloses microorganisms and methods of producing GNAQ/GNA11 inhibitors and methods of making antibody drug conjugates of anti-PMEL17 antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The disclosure also relates to formulations comprising antibody drug co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: D'ALESSIO, Joseph Anthony, IYER, Shwetha, MAUDENS, Pierre, HAINZL, Dominik, KHERA, Eshita, FESSLER, Boris, FAN, Liqiong, MANCHADO ROBLES, Eusebio, BLUEMMEL, Anne-Sophie, GABRIEL, Doris, YERRAMILLI-RAO, Padmaja, WUERSCH, Kuno, PISTORIUS, Dominik, HOFFMASTER, Keith, ROMANET, Vincent, RAMOT, Roee, BUNTIN, Kathrin
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This application discloses microorganisms and methods of producing GNAQ/GNA11 inhibitors and methods of making antibody drug conjugates of anti-PMEL17 antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The disclosure also relates to formulations comprising antibody drug conjugates of anti-PMEL17 antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor and methods of treating or preventing cancer using the formulations.